chr6-160254732-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_003058.4(SLC22A2):c.518+1882A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.912 in 152,230 control chromosomes in the GnomAD database, including 63,374 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.91 ( 63374 hom., cov: 32)
Consequence
SLC22A2
NM_003058.4 intron
NM_003058.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.49
Publications
25 publications found
Genes affected
SLC22A2 (HGNC:10966): (solute carrier family 22 member 2) Polyspecific organic cation transporters in the liver, kidney, intestine, and other organs are critical for elimination of many endogenous small organic cations as well as a wide array of drugs and environmental toxins. This gene is one of three similar cation transporter genes located in a cluster on chromosome 6. The encoded protein contains twelve putative transmembrane domains and is a plasma integral membrane protein. It is found primarily in the kidney, where it may mediate the first step in cation reabsorption. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.94 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC22A2 | ENST00000366953.8 | c.518+1882A>G | intron_variant | Intron 2 of 10 | 1 | NM_003058.4 | ENSP00000355920.3 | |||
ENSG00000294112 | ENST00000721154.1 | n.153T>C | non_coding_transcript_exon_variant | Exon 2 of 3 | ||||||
SLC22A2 | ENST00000366952.1 | c.455+1882A>G | intron_variant | Intron 4 of 7 | 5 | ENSP00000355919.1 | ||||
SLC22A2 | ENST00000491092.1 | n.415+3612A>G | intron_variant | Intron 1 of 9 | 5 |
Frequencies
GnomAD3 genomes AF: 0.912 AC: 138688AN: 152112Hom.: 63300 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
138688
AN:
152112
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.912 AC: 138821AN: 152230Hom.: 63374 Cov.: 32 AF XY: 0.914 AC XY: 68020AN XY: 74434 show subpopulations
GnomAD4 genome
AF:
AC:
138821
AN:
152230
Hom.:
Cov.:
32
AF XY:
AC XY:
68020
AN XY:
74434
show subpopulations
African (AFR)
AF:
AC:
38076
AN:
41532
American (AMR)
AF:
AC:
14223
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
2980
AN:
3466
East Asian (EAS)
AF:
AC:
4980
AN:
5174
South Asian (SAS)
AF:
AC:
4231
AN:
4816
European-Finnish (FIN)
AF:
AC:
9983
AN:
10612
Middle Eastern (MID)
AF:
AC:
251
AN:
294
European-Non Finnish (NFE)
AF:
AC:
61347
AN:
68006
Other (OTH)
AF:
AC:
1931
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
633
1266
1898
2531
3164
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3222
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.